Trial
NCT03864419
Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
—
Condition
Burkitt Lymphoma
Intervention
Rituximab and Hyaluronidase Human
Why stopped
Closed per SRC Low Accrual Policy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-03